Vera Therapeutics (VERA) was Smart Insider's stock pick of the week after the company's non-executive director Patrick Enright purchased $5.3 million worth of company shares at $21.11 apiece on June 24, raising his stake by 5%.
Enright made these purchases indirectly on behalf of Longitude Capital, where he is cofounder and managing director, Smart Insider said in a Tuesday note, adding that the purchases took Longitude's stake to 8.5%.
Since joining in 2020, Enright has made three subscriptions, with the latest being his first open-market purchase, the note said, adding that it is "encouraging" that Enright is now purchasing at three times the price he paid two years earlier.
Smart Insider ranked the stock +N, notable and positive signal, on June 26.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。